Provided by Tiger Fintech (Singapore) Pte. Ltd.

Recursion Pharmaceuticals, Inc.

4.37
+0.19004.55%
Post-market: 4.380.0100+0.23%19:59 EDT
Volume:19.14M
Turnover:83.77M
Market Cap:1.78B
PE:-2.40
High:4.52
Open:4.18
Low:4.18
Close:4.18
Loading ...

Why Biotech Stocks Like Recursion Pharmaceuticals, CRISPR Therapeutics, and Summit Therapeutics Plunged Today

Motley Fool
·
01 Apr

Why Recursion Pharmaceuticals Inc. (RXRX) Performed Worst On Tuesday?

Insider Monkey
·
26 Mar

Cathie Wood’s ARK Investment buys 161K shares of Recursion Pharmaceuticals today

TIPRANKS
·
21 Mar

Why Recursion Pharmaceuticals (RXRX) Dipped More Than Broader Market Today

Zacks
·
21 Mar

Recursion Pharmaceuticals (NasdaqGS:RXRX) Jumps 12% Following US$500M Equity Offering

Simply Wall St.
·
19 Mar

Why Recursion Pharmaceuticals (RXRX) Went Up on Monday?

Insider Monkey
·
18 Mar

Recursion Pharmaceuticals Strengthens Board with New Appointments

TIPRANKS
·
18 Mar

Press Release: Recursion Bolsters Board of Directors with Former FDA Principal Deputy Commissioner Dr. Namandjé Bumpus and Mammoth Biosciences COO and CFO Elaine Sun

Dow Jones
·
18 Mar

Recursion Pharmaceuticals call volume above normal and directionally bullish

TIPRANKS
·
17 Mar

Why Recursion Pharmaceuticals Stock Is Sinking Today

Motley Fool
·
10 Mar

Stock Track | Recursion Pharmaceuticals Soars 5.13% on Optimism Around Upcoming Clinical Milestones

Stock Track
·
08 Mar

4 Things You Need to Know if You Buy Recursion Pharmaceuticals Stock Today

Motley Fool
·
07 Mar

Down Over 40%, Is Recursion Pharmaceuticals a Buy on the Dip?

Motley Fool
·
06 Mar

News Flash: Analysts Just Made A Sizeable Upgrade To Their Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Forecasts

Simply Wall St.
·
05 Mar

AI Biotech Stocks Shined, With Ginkgo Up 8%, Recursion And Absci Up 4%, Crispr Up 3%

Tiger Newspress
·
05 Mar

Analysts Offer Insights on Healthcare Companies: Ramsay Health Care (OtherRMSYF) and Recursion Pharmaceuticals (RXRX)

TIPRANKS
·
05 Mar

Why Recursion Pharmaceuticals, Inc. (RXRX) Crashed on Monday

Insider Monkey
·
05 Mar

Recursion Pharmaceuticals Inc (RXRX) Q4 2024 Earnings Call Highlights: Strong Financial ...

GuruFocus.com
·
04 Mar

Recursion Pharmaceuticals (NasdaqGS:RXRX) Surges 6% Following US$500 Million Follow-On Equity Offering

Simply Wall St.
·
04 Mar

Stock Track | Recursion Pharmaceuticals Plunges 5.06% on Wider-Than-Expected Q4 Loss

Stock Track
·
03 Mar